Current Neurology and Neuroscience Reports

, Volume 6, Issue 5, pp 355–357

The pleomorphic pathology of inherited parkinson’s disease: Lessons from LRRK2

Invited Commentary


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Moore DJ, West AB, Dawson VL, Dawson TM: Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci 2005, 28:57–87.PubMedCrossRefGoogle Scholar
  2. 2.
    Zimprich A, Biskup S, Leitner P, et al.: Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 2004, 44:601–607.PubMedCrossRefGoogle Scholar
  3. 3.
    Paisan-Ruiz C, Jain S, Evans EW, et al.: Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 2004, 44:595–600.PubMedCrossRefGoogle Scholar
  4. 4.
    Bosgraaf L, Van Haastert PJ: Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 2003, 1643:5–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Mata IF, Kachergus JM, Taylor JP, et al.: Lrrk2 pathogenic substitutions in Parkinson’s disease. Neurogenetics 2005, 6:171–177.PubMedCrossRefGoogle Scholar
  6. 6.
    Berg D, Schweitzer K, Leitner P, et al.: Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson’s disease. Brain 2005, 128:3000–3011.PubMedGoogle Scholar
  7. 7.
    Khan NL, Jain S, Lynch JM, et al.: Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson’s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005, 128:2786–2796.PubMedCrossRefGoogle Scholar
  8. 8.
    Di Fonzo A, Tassorelli C, De Mari M, et al.: Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson’s disease. Eur J Hum Genet 2006, 14:322–331.PubMedCrossRefGoogle Scholar
  9. 9.
    Lesage S, Durr A, Tazir M, et al.: LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs. N Engl J Med 2006, 354:422–423.PubMedCrossRefGoogle Scholar
  10. 10.
    Ozelius LJ, Senthil G, Saunders-Pullman R, et al.: LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N Engl J Med 2006, 354:424–425.PubMedCrossRefGoogle Scholar
  11. 11.
    Bras JM, Guerreiro RJ, Ribeiro MH, et al.: G2019S dardarin substitution is a common cause of Parkinson’s disease in a Portuguese cohort. Mov Disord 2005, 20:1653–1655.PubMedCrossRefGoogle Scholar
  12. 12.
    Gaig C, Ezquerra M, Marti MJ, et al.: LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 2006, 63:377–382.PubMedCrossRefGoogle Scholar
  13. 13.
    Goldwurm S, Di Fonzo A, Simons EJ, et al.: The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor. J Med Genet 2005, 42:e65.PubMedCrossRefGoogle Scholar
  14. 14.
    Funayama M, Hasegawa K, Kowa H, et al.: A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002, 51:296–301.PubMedCrossRefGoogle Scholar
  15. 15.
    Wszolek ZK, Vieregge P, Uitti RJ, et al.: German-Canadian family (Family A) with parkinsonism, amyotrophy, and dementia—longitudinal observations. Parkinsonism Relat Disord 1997, 3:125–139.PubMedCrossRefGoogle Scholar
  16. 16.
    Wszolek ZK, Pfeiffer RF, Tsuboi Y, et al.: Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004, 62:1619–1622.PubMedGoogle Scholar
  17. 17.
    Gilks WP, Abou-Sleiman PM, Gandhi S, et al.: A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet 2005, 365:415–416.PubMedGoogle Scholar
  18. 18.
    Ross OA, Toft M, Whittle AJ, et al.: Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388–393.PubMedCrossRefGoogle Scholar
  19. 19.
    Giasson BI, Covy JP, Bonini NM, et al.: Biochemical and pathological characterization of Lrrk2. Ann Neurol 2006, 59:315–322.PubMedCrossRefGoogle Scholar
  20. 20.
    Greggio E, Jain S, Kingsbury A, et al.: Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 2006, In press.Google Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Department of Clinical GeneticsErasmus MCCA RotterdamThe Netherlands

Personalised recommendations